cryptocurrency interest- Top searches

Huaxi Securities: Maintaining the "Buy" rating of this century is expected to outperform the industry. Huaxi Securities Research Report pointed out that the Spring Festival is the most rigid peak season for liquor demand in a year, and it is also the key node for liquor companies to complete sales and promote marketing. It is expected that the demand for business banquets, corporate annual meetings, family gatherings, gifts from relatives and friends will be stronger, and the marketing of the industry will be improved after the Spring Festival. This century (603369.SH In the short and medium term, in order to seize the window period of intensive cultivation in the province, it is relatively more important for the company to improve its market share and expand its market coverage. It is considered that under the trend of intensified competition in the industry, it is not excluded that the company can maintain its current investment and even increase its investment in a targeted manner, so it is relatively cautious to calculate the profit elasticity. At present, the industry has entered a period of slowdown and the company will be more pragmatic in setting goals. However, the company's own advantages are still accumulating and it is expected to outperform the industry relatively. Maintain the "buy" rating.Yuanyuan Communication: The plan being evaluated and negotiated between the company and toy manufacturers does not involve ByteDance, and the results of subsequent negotiations are still uncertain.Zhongzhou Special Materials: Shareholders have transferred and reduced their shares by more than 1%. Zhongzhou Special Materials announced that shareholders holding more than 5% have transferred their shares internally and reduced their shares by more than 1%. After the shareholder completed the internal transfer among the concerted parties, its shareholding ratio changed accordingly. At the same time, the shareholder reduced his shares through the secondary market, and the reduction ratio exceeded 1%. This share change is mainly for the adjustment of shareholding within the company's shareholders, and will not have a significant impact on the company's governance structure and daily operations.

Expert: Central enterprises will continue to recruit in A-shares. On the evening of December 9, Huada Jiutian, a domestic EDA leader, announced that China Electronic Information Industry Group Co., Ltd. will become the actual controller of the company. So far, the number of A-share listed companies "incorporated" by central enterprises reached 10 in 2024. The end of 2024 is an important node for central enterprises to optimize the layout of listed platforms. The Work Plan for Improving the Quality of Listed Companies Controlled by Central Enterprises previously issued by the State-owned Assets Supervision and Administration Commission of the State Council made it clear that the adjustment and revitalization of the listing platform should be basically completed by the end of 2024, and it is supported to revitalize through absorption and merger, asset restructuring and cross-market operation, or to withdraw through free transfer and equity transfer, so as to further focus on the main business and advantageous areas. Looking forward to the next layout rhythm of central enterprises in the capital market, many experts interviewed by reporters believe that the pace of "recruiting" of central enterprises in A shares will continue. In the coming period, the cases of central enterprises strengthening their main business through capital operation and giving play to their strategic support and industrial leading functions will be on the rise. (shanghai securities news)ZTE signed a strategic cooperation agreement with Daiyu and Midea Group. Recently, ZTE signed a strategic cooperation agreement with Daiyu and Midea Group in Chengdu. In the future, the two sides will carry out in-depth cooperation in VR space, AR application and MR interaction.Wells Fargo: Reduce the target price of Dow Chemical from $60 to $55, and maintain the "overweight" rating.

During the year, there were 461 new indices, and the index investment fever continued to climb. On December 10th, in order to meet the investment demand of diversified indices, CSI Index Co., Ltd. officially released five new indices, including CSI 1000 Growth Index, CSI 1000 Value Index, CSI 2000 Growth Index, CSI 2000 Value Index and CSI 1000 Quality Balance Strategy Index. With the "listing" of the above five indexes, the number of newly-issued indexes reached 461 during the year, covering categories such as strategy, style, scale, industry, theme and other fixed-income indexes; Related index asset classes include stocks, fixed income, funds and futures. At the same time, the secondary market, this year, the heat of indexed investment is also high. Looking forward to the future, with the continuous vigorous growth of market demand and unabated heat, and the precise guidance and strong support from the supervisory level, the indexed investment ecology will become more and more perfect. (Securities Daily) Hengrui Pharma: HRS-4729 injection was approved for clinical trial. Hengrui Pharma announced that the company and its subsidiary Fujian Sheng Di Pharmaceutical Co., Ltd. received the Notice of Approval for Clinical Trial of HRS-4729 injection approved and issued by National Medical Products Administration. The drug is a polypeptide drug independently developed, and it is a GLP-1R/GIPR/GCGR triple agonist, which is suitable for obese or overweight patients. Up to now, HRS-4729 injection has invested about 19.56 million yuan in research and development.